Cogentech

BiLiGeCT Project

Publications

  1. Annalaura Cordaro 1, Giulia Neri 1, Maria Teresa Sciortino 1, Angela Scala 1 2, Anna Piperno 1 2
    Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis
    Nanomaterials (Basel) 2020 May 26;10(6):1014 | PMID: 32466536, PMCID: PMC7353367, DOI: 10.3390/nano10061014
  2. Russo, M., Pompei, S., Sogari, A. et al.
    A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells.
    Nat Genet 54, 976–984 (2022).
  3. Merlini A, Centomo ML, Ferrero G, Chiabotto G, Miglio U, Berrino E, Giordano G, Brusco S, Pisacane A, Maldi E, Sarotto I, Capozzi F, Lano C, Isella C, Crisafulli G, Aglietta M, Dei Tos AP, Sbaraglia M, Sangiolo D, D'Ambrosio L, Bardelli A, Pignochino Y, Grignani G.
    DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
    Front Oncol. 2022 Aug 30;12:844250. | doi: 10.3389/fonc.2022.844250. PMID: 36110934; PMCID: PMC9469659.
  4. Pergolizzi M, Bizzozero L, Maione F, Maldi E, Isella C, Macagno M, Mariella E, Bardelli A, Medico E, Marchiò C, Serini G, Di Nicolantonio F, Bussolino F, Arese M.
    The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.
    J Exp Clin Cancer Res. 2022 Sep 2;41(1):266. | doi: 10.1186/s13046-022-02465-4. PMID: 36056393; PMCID: PMC9438340
  5. Sartore-Bianchi, A., Pietrantonio, F., Lonardi, S. et al.
    Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
    Nat Med 28, 1612–1618 (2022).
  6. Crisafulli G, Sartore-Bianchi A, Lazzari L, Pietrantonio F, Amatu A, Macagno M, Barault L, Cassingena A, Bartolini A, Luraghi P, Mauri G, Battuello P, Personeni N, Zampino MG, Pessei V, Vitiello PP, Tosi F, Idotta L, Morano F, Valtorta E, Bonoldi E, Germano G, Di Nicolantonio F, Marsoni S, Siena S, Bardelli A.
    Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
    Cancer Discov. 2022 Jul 6;12(7):1656-1675. | doi: 10.1158/2159-8290.CD-21-1434. PMID: 35522273; PMCID: PMC9394384.
  7. Mauri, G., Vitiello, P.P., Sogari, A. et al.
    Liquid biopsies to monitor and direct cancer treatment in colorectal cancer.
    Br J Cancer 127, 394–407 (2022).
  8. Pignochino Y, Crisafulli G, Giordano G, Merlini A, Berrino E, Centomo ML, Chiabotto G, Brusco S, Basiricò M, Maldi E, Pisacane A, Leuci V, Sangiolo D, D'Ambrosio L, Aglietta M, Kasper B, Bardelli A, Grignani G.
    PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.
    Cancers (Basel). 2021 Dec 15;13(24):6295. | doi: 10.3390/cancers13246295. PMID: 34944915; PMCID: PMC8699802.
  9. Di Nicolantonio F, Vitiello PP, Marsoni S, Siena S, Tabernero J, Trusolino L, Bernards R, Bardelli A.
    Precision oncology in metastatic colorectal cancer - from biology to medicine.
    Nat Rev Clin Oncol. 2021 Aug;18(8):506-525. | doi: 10.1038/s41571-021-00495-z. Epub 2021 Apr 16. PMID: 33864051.
  10. Russo, M., Pompei, S., Sogari, A. et al.
    A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells
    Nat Genet 54, 976–984 (2022).
  11. Signore M, Alfonsi R, Federici G, Nanni S, Addario A, Bertuccini L, Aiello A, Di Pace AL, Sperduti I, Muto G, Giacobbe A, Collura D, Brunetto L, Simone G, Costantini M, Crinò L, Rossi S, Tabolacci C, Diociaiuti M, Merlino T, Gallucci M, Sentinelli S, Papalia R, De Maria R, Bonci D.
    Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
    Cell Death Dis. 2021 Jun 21;12(7):636. | doi: 10.1038/s41419-021-03909-z. PMID: 34155195; PMCID: PMC8215487.